Free Newsletter
New method spurs proliferation of adult stem cells
Scientists at MIT have perfected a new method for encouraging the proliferation of adult stem cells, improving their effectiveness as a therapy for repairing damage to the body. The researchers focused on the growth factor EGF, which has demonstrated an ability to encourage stem cell proliferation after attaching itself to stem cell receptors. The problem with EGF in the past is that the cell eventually absorbs EGF. At MIT, though, the group "tethered" EGF to a scaffold, preventing absorption.
"Putting them on a scaffold is appealing because then you can control the concentration and location and so forth," MIT professor Linda Griffith said. The ceramic and polymer scaffold, which remains in the patient's body during healing but then resorbs, also provides structure for the stem cells as they grow into new bone cells. "We found that when EGF was tethered to the surface it elicited different cell responses than it did when given to cells in the usual soluble form," Griffith said. "When tethered, it protected the cells from being killed by pro-death inflammatory signals. The soluble version of the factor did not protect cells."
- read the report on the MIT study
Related Articles:
Adult stem cell therapy begins human trial. Report
Scientists tout adult stem cell study results. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: